Defitelio 80mg/ml (Defibrotide Sodium Vials) 80mg/ml x 2.5ml

Defitelio 80mg/ml (Defibrotide Sodium) is an injectable solution for vascular conditions. Used to support blood flow and reduce clot-related complications. Suitable for patients requiring venous occlusive disease management. Short-term use under medical supervision.

Strength

80mg/ml x 2.5ml

Pack Size

10s

Storage

Ambient

Manufacturer / TM Owner

Drac Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Defitelio 80mg/ml is primarily used to treat severe hepatic veno-occlusive disease (VOD) following stem cell transplants. It helps improve blood flow and reduce clot formation in small veins. Often prescribed when VOD causes liver dysfunction or kidney issues. May also support recovery in related vascular conditions.

Side Effects

Defitelio 80mg/ml works by enhancing blood flow and reducing clot formation in small blood vessels. Patients may notice improved circulation and reduced swelling over time. Some experience mild warmth or redness at the injection site. Effects vary based on individual health conditions.

Precautions & Warnings

Store Defitelio 80mg/ml at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid exposure to extreme temperatures during transport. Always check the vial for particles or discoloration before use. Consult a healthcare provider if pregnant or breastfeeding.

Avoid Interactions

Defitelio 80mg/ml may interact with blood thinners or antiplatelet drugs, increasing bleeding risk. Avoid combining with high-dose NSAIDs like ibuprofen or aspirin unless directed. Alcohol and certain supplements (e.g., ginkgo biloba) may also pose risks. Always disclose all medications to your doctor.

References

Frequently Asked Questions

It is used to treat severe hepatic veno-occlusive disease (VOD) after stem cell transplants.

It is given as an intravenous infusion by a healthcare professional.

Defitelio 80mg/ml requires a prescription and is available through licensed pharmacies.

Mild side effects may include nausea, low blood pressure, or bleeding at the injection site.

Consult a healthcare provider; its safety during pregnancy has not been established.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.